LIVE
⭐7.1M influencer listings 🏢82.1K sponsor listings 🌍100.7B combined audience reach 📊13 platforms indexed 🗺️130+ countries covered 🏷️10,000+ niches 🦋3.1M Bluesky creators 🎙️1.4M podcast creators 🟣1.2M Twitch creators 📈454.4K Pinterest creators 🥊235K Kick creators 𝕏219.4K X creators 🐘210K Mastodon creators 171.6K YouTube creators 🎵104.1K TikTok creators ✈️94.4K Telegram creators 🎮12.2K Discord creators 📈4.9K Substack creators 🎬4.6K Rumble creators 🧵2.9K Threads creators ⭐7.1M influencer listings 🏢82.1K sponsor listings 🌍100.7B combined audience reach 📊13 platforms indexed 🗺️130+ countries covered 🏷️10,000+ niches 🦋3.1M Bluesky creators 🎙️1.4M podcast creators 🟣1.2M Twitch creators 📈454.4K Pinterest creators 🥊235K Kick creators 𝕏219.4K X creators 🐘210K Mastodon creators 171.6K YouTube creators 🎵104.1K TikTok creators ✈️94.4K Telegram creators 🎮12.2K Discord creators 📈4.9K Substack creators 🎬4.6K Rumble creators 🧵2.9K Threads creators
Johnson & Johnson

Johnson & Johnson Add us as a preferred source on Google

X @jnjnews
⚔ Compare ☆ Follow Own this channel?
🔄 Data last refreshed 21 days ago
🤝

Make a deal with Johnson & Johnson

🔒 Paid proposals held safely in escrow — released only when the work's approved.

📣Sponsored postOne tweet with your link and creative. $1,936→ 🧵Sponsored threadA multi-tweet thread — X rewards long-form, threads out-reac… $4,840→ 🎬Sponsored video postA dedicated video tweet — X pushes video hard, so it gets pr… $2,710→ 📌Pinned postA sponsored post pinned to the top of my profile for the mon… $5,808/mo→ 📍Post + pin comboA sponsored post that also stays pinned for a set number of … $3,098→ 🔁Repost / quote-tweet packageI repost or quote-tweet your posts through the month — distr… $3,872/mo→ 🔗Bio link placementYour link in my bio for the month — X allows only one, so it… $2,904/mo→ 🎙️X Spaces appearance / hostI host or feature you in an X Space (live audio) — a branded… $3,872→ 🤝Cross-promo / mutual shoutoutWe shout each other out — a value swap between accounts. Swap→ 🎬UGC HireBranded content for your own channels & ads from $847→ 🎙️Podcast guest spotInvite Johnson & Johnson onto your podcast (~45 min, remote) $847→ 📞1:1 ConsultPaid video call — advice, coaching or Q&A $136/hr→

Every booking is a normal escrow-protected deal.

Followers
242K
Posts
15.7K
Following
135
Account age
17 yrs
🎁 Free analysisfor Johnson & Johnson
🕵️Fake Followers CheckReal-audience % & bot risk→ 📊Engagement rateBenchmarked vs. peers→ 💰What they chargeFair sponsored-post price→

Known for

Struggling to see clearly due to astigmatism and finding it hard to focus up close from presbyopia? We're changing that with ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM—the first and only daily disposable contact lens designed to treat both astigmatism and presbyopia.¹ 26.6K views Struggling to see clearly due to astigmatism and finding it hard to focus up close from presbyopia? We're changing that with ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM—the first and only daily disposable contact lens designed to treat both astigmatism and presbyopia.¹ Join our Q1 2025 #earnings call and webcast now: https://t.co/rPwdB5Fw93 $JNJ 22.9K views Join our Q1 2025 #earnings call and webcast now: https://t.co/rPwdB5Fw93 $JNJ Today we’re announcing our intent to separate our Orthopaedics business. We’re confident this move would further strengthen the focus of Johnson & Johnson on our six key growth areas – Oncology, Immunology, Neuroscience, Cardiovascular, Surgery, and Vision. It would also 8.2K views Today we’re announcing our intent to separate our Orthopaedics business. We’re confident this move would further strengthen the focus of Johnson & Johnson on our six key growth areas – Oncology, Immunology, Neuroscience, Cardiovascular, Surgery, and Vision. It would also Today, the U.S. FDA approved one of our therapies as an adjunctive treatment for adults living with major depressive disorder (MDD) – offering hope to the 2 in 3 patients who experience residual symptoms despite their antidepressant treatment. Learn more here: 6.3K views Today, the U.S. FDA approved one of our therapies as an adjunctive treatment for adults living with major depressive disorder (MDD) – offering hope to the 2 in 3 patients who experience residual symptoms despite their antidepressant treatment. Learn more here:

📊 Post performance

4.4K
Avg views / post
1.8%
Reach vs followers
Feb 2009
On X since

🔥 Top post: Struggling to see clearly due to astigmatism and finding it hard · 26.6K views

📊 Activity & format

Posting cadence
0.27 / week
A lower-frequency account — each post lands with more weight.
Content mix
Mostly video
Recent: 12 video · 6 image · 0 text.
Follower / following
1.8K×
Follows 135 back. A strong ratio — an audience that follows them, not a follow-for-follow network.

Recent posts

View on X ↗
▶ 🔥 Top post Struggling to see clearly due to astigmatism and finding it hard to focus up close from presbyopia? We're changing that with ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM—the first and only daily disposable contact lens designed to treat both astigmatism and presbyopia.¹ 26.6K❤ 38🔁 119
▶ #NEWS: The U.S. FDA has authorized the OTTAVA™ Robotic Surgical System—the world's first table-integrated soft tissue robotic system. This U.S. milestone reflects years of collaboration with surgeons, engineers and clinical teams to reth… 3.4K❤ 12🔁 7 ▶ Great care takes more than skill—it takes dedication, creativity and drive. Nominations are still open for the @TIME Healthcare Champion of the Year, in partnership with J&J, a branded award we're proud to help bring to life. It look… 2.8K❤ 5🔁 1 ▶ Healthcare professionals shape the future of care every day through innovation, resilience and a deep commitment to the people they serve. That's why we at J&J are excited to partner with @TIME to launch the Healthcare Champion of th… 3.5K❤ 5🔁 1 ▶ Join our Q2 2026 #earnings call and webcast now: https://t.co/9jlOHySezd $JNJ 2.2K❤ 11🔁 5 We’re committed to helping improve sight for more than 40 million patients in the U.S. and around the world. This week, we announced a more than $1 billion investment in Jacksonville, Florida to strengthen our Vision operations. As part … 2.9K❤ 17🔁 14 ▶ Join our Q1 2026 #earnings call and webcast now: https://t.co/nPjnmv8JMK $JNJ 5.2K❤ 14🔁 21 ▶ #NEWS: The U.S. FDA has approved our new treatment for patients 12 and older with moderate to severe plaque psoriasis, bringing a fundamentally different systemic treatment option to patients and physicians. Learn more: https://t.co/9Z2Xl… 5.8K❤ 28🔁 21 #NEWS: The U.S. FDA has approved a breakthrough extended depth of focus (EDOF) intraocular lens intended for use in cataract surgery. This advanced technology is designed to deliver clarity of vision with reduced visual symptoms, helping … 3.9K❤ 21🔁 10 ▶ Join our Q4 and full-year 2025 #earnings call and webcast now: https://t.co/3wnWWgqxfN $JNJ 5K❤ 23🔁 14 ▶ #NEWS The U.S. FDA has approved a new subcutaneously administered therapy for the treatment of EGFR-mutated advanced non–small cell lung cancer (NSCLC) in adults. This treatment option brings us one step closer to delivering more personal… 5.8K❤ 26🔁 29 ▶ Today, the U.S. FDA approved one of our therapies as an adjunctive treatment for adults living with major depressive disorder (MDD) – offering hope to the 2 in 3 patients who experience residual symptoms despite their antidepressant treatm… 6.3K❤ 30🔁 34 What's the difference between AI hype and AI value in healthcare? At #HLTHUSA, our CIO Jim Swanson shared what successful teams focus on to deliver real results that advance health. 5.8K❤ 32🔁 33

💡 Facts

🗓️Joined X in 2009 — 17 years ago.
👁️Averages 4.4K views per post.
📤Posts about 0.3× per week.
💬0.02% engagement rate.
🏅Earned the 100K Followers for passing 100K followers.

🕵️ Fake follower check

Estimated
37/100
Low Credibility score
66%
Mixed Real audience
Medium Fake-follower risk
High Data confidence
  • Est. 66% real, active audience · Medium fake-follower risk.
  • Low engagement (~1.8% of followers engage each post) — a sign of an inflated or inactive audience.
  • Organic base — far more followers than accounts it follows.
  • Established account (17+ years old).
  • 0.02% engagement — below the ~14.4% typical for this size.

Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.

About

Follow us to see how we're solving the world's toughest health challenges. Community Guidelines: http://social.jnj.com/guidelines

📸 Gallery

#NEWS: The U.S. FDA has authorized the OTTAVA™ Robotic Surgical System—the world's first table-integrated soft tissue robotic system. This U.S. milestone reflects years of collaboration with surgeons, engineers and clinical teams to rethink how robotic surgery can better serve Great care takes more than skill—it takes dedication, creativity and drive. Nominations are still open for the @TIME Healthcare Champion of the Year, in partnership with J&J, a branded award we're proud to help bring to life. It looks beyond titles to recognize the people Healthcare professionals shape the future of care every day through innovation, resilience and a deep commitment to the people they serve. That's why we at J&J are excited to partner with @TIME to launch the Healthcare Champion of the Year, a branded award recognizing a leader Join our Q2 2026 #earnings call and webcast now: https://t.co/9jlOHySezd $JNJ We’re committed to helping improve sight for more than 40 million patients in the U.S. and around the world. This week, we announced a more than $1 billion investment in Jacksonville, Florida to strengthen our Vision operations. As part of our $55 billion U.S. investment in Join our Q1 2026 #earnings call and webcast now: https://t.co/nPjnmv8JMK $JNJ #NEWS: The U.S. FDA has approved our new treatment for patients 12 and older with moderate to severe plaque psoriasis, bringing a fundamentally different systemic treatment option to patients and physicians. Learn more: https://t.co/9Z2XlzapVC For U.S. Audience Only #NEWS: The U.S. FDA has approved a breakthrough extended depth of focus (EDOF) intraocular lens intended for use in cataract surgery. This advanced technology is designed to deliver clarity of vision with reduced visual symptoms, helping patients see the world as they expect¹.

🔀 Audience overlap

Estimated

Estimated shared audience with similar creators — useful for avoiding overlap (or doubling down) when planning a campaign.

Aimlabs Aimlabs 18% Capgemini Capgemini 16% Keen Software House Keen Software House 13% Nintendo Versus Nintendo Versus 13% Zafar Mirza Zafar Mirza 11% Clinton Foundation Clinton Foundation 10%

More like this

Find more →
X ＋
Clinton Foundation
Clinton Foundation
@clintonfdn
730K Followers
X ＋
Zafar Mirza
Zafar Mirza ✓
@zfrmrza
241.7K Followers
X ＋
Capgemini
Capgemini
@capgemini
134.2K Followers
X ＋
Aimlabs
Aimlabs
@aimlab
118K Followers
X ＋
Keen Software House
Keen Software House
@keenswh
10.7K Followers
X ＋
Nintendo Versus
Nintendo Versus ✓
@nintendovs
242K Followers

Frequently asked questions

How much does Johnson & Johnson charge for a sponsorship?
Johnson & Johnson hasn't published fixed prices yet. Send a proposal through SocialDB and agree terms directly — your payment is held in escrow until the work is approved.
How do I contact Johnson & Johnson for a brand deal or collaboration?
Send a paid deal or collab request right here on SocialDB — we notify Johnson & Johnson, and once they accept, your payment is held safely in escrow and released when the work is approved. You don't need to track down an email.
How many followers does Johnson & Johnson have?
Johnson & Johnson has 242,009 followers on X.

✉ Message Johnson & Johnson

Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.

  • ✓ Message any influencer from their listing
  • ✓ The influencer gets notified by email
  • ✓ Manage every conversation in one inbox
See Pro $9.95/mo →

Already Pro? Log in.

🎤 Event / appearance with Johnson & Johnson

Booking an event / appearance is a Pro feature. Upgrade to book Johnson & Johnson for an in-person or virtual appearance — payment held safely in escrow until the event is done.

  • ✓ Book them for events, livestreams, panels & more
  • ✓ Johnson & Johnson gets notified by email
  • ✓ Fee held in escrow, released after the appearance
See Pro $9.95/mo →

Already Pro? Log in.

Auto-generated from X's public data — no affiliation with or endorsement by SocialDB. Is this you? Claim it · Remove

✉️ Contact